Your browser doesn't support javascript.
loading
Superior Boosting of Neutralizing Titers Against Omicron SARS-CoV-2 Variants by Heterologous SCB-2019 Vaccine vs a Homologous Booster in CoronaVac-Primed Adults.
Roa, Camilo C; de Los Reyes, Mari Rose A; Plennevaux, Eric; Smolenov, Igor; Hu, Branda; Gao, Faith; Ilagan, Hannalyn; Ambrosino, Donna; Siber, George; Clemens, Ralf.
Affiliation
  • Roa CC; Department of Physiology, Philippine General Hospital, University of the Philippines, Manila, Philippines.
  • de Los Reyes MRA; Las Pinas Doctors Hospital, Las Pinas City, Philippines.
  • Plennevaux E; Clover Biopharmaceuticals, Cambridge, United Kingdom.
  • Smolenov I; Clover Biopharmaceuticals, Boston, Massachusetts, USA.
  • Hu B; Clover Biopharmaceuticals, Boston, Massachusetts, USA.
  • Gao F; Clover Biopharmaceuticals, Boston, Massachusetts, USA.
  • Ilagan H; Clover Biopharmaceuticals, Boston, Massachusetts, USA.
  • Ambrosino D; Independent Advisor, Stuart, Florida, USA.
  • Siber G; Independent Advisor, New York, New York, USA.
  • Clemens R; International Vaccine Institute, Seoul, Republic of Korea.
J Infect Dis ; 228(9): 1253-1262, 2023 11 02.
Article in En | MEDLINE | ID: mdl-37439701
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: J Infect Dis Year: 2023 Type: Article Affiliation country: Philippines
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: J Infect Dis Year: 2023 Type: Article Affiliation country: Philippines